Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion type Assertion NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_head.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion description "[Although advanced T stage and preoperative chemotherapy were statistically significant in univariate analysis, unmethylation of DAPK (p = 0.030) and hypermethylation of RARbetaP2 (p = 0.014), as well as advanced T stage (p = 0.075) and preoperative chemotherapy (p = 0.025), were significant risk factors in multivariate analysis for early recurrence in the remaining lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion evidence source_evidence_literature NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion SIO_000772 15797047 NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion wasDerivedFrom befree-20140225 NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.
- NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_assertion wasGeneratedBy ECO_0000203 NP650653.RArvI51RH6rsL2jK-CD0eJH5-DeSBb7N44TbIIvCyjLJ8130_provenance.